Experimental browser for the Atmosphere
Exciting updates in the development of the NGDI UBC Oral Amphotericin B Signature Technology recently licensed to EluciDx Ltd. Treatment for Cryptococcal Meningitis in patients with HIV would be ground-breaking! @msf.ca @madhupai.bsky.social @who.int @lshtm.bsky.social @isntd.org
Mar 29, 2025, 7:19 PM
{
"text": "Exciting updates in the development of the NGDI UBC Oral Amphotericin B Signature Technology recently licensed to EluciDx Ltd. Treatment for Cryptococcal Meningitis in patients with HIV would be ground-breaking! @msf.ca @madhupai.bsky.social @who.int @lshtm.bsky.social @isntd.org",
"$type": "app.bsky.feed.post",
"embed": {
"$type": "app.bsky.embed.images",
"images": [
{
"alt": "",
"image": {
"$type": "blob",
"ref": {
"$link": "bafkreielhvgcasb2cz4plujrspdxbknj5ca3rmaso36i6dztm2xemeahia"
},
"mimeType": "image/jpeg",
"size": 619306
},
"aspectRatio": {
"width": 576,
"height": 765
}
}
]
},
"langs": [
"en"
],
"facets": [
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 219,
"byteStart": 212
},
"features": [
{
"did": "did:plc:skmvc4cstxwtt3oct44fpf66",
"$type": "app.bsky.richtext.facet#mention"
}
]
},
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 241,
"byteStart": 220
},
"features": [
{
"did": "did:plc:pbaaelwaezgvqyvg3er45cfu",
"$type": "app.bsky.richtext.facet#mention"
}
]
},
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 250,
"byteStart": 242
},
"features": [
{
"did": "did:plc:univ47kzorwxjih3lqzrnwmv",
"$type": "app.bsky.richtext.facet#mention"
}
]
},
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 269,
"byteStart": 251
},
"features": [
{
"did": "did:plc:wwfkqabqdkg53w5gw2lrln3q",
"$type": "app.bsky.richtext.facet#mention"
}
]
},
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 280,
"byteStart": 270
},
"features": [
{
"did": "did:plc:aegdkke76vkfp5ecyw3cgk4k",
"$type": "app.bsky.richtext.facet#mention"
}
]
}
],
"createdAt": "2025-03-29T19:19:51.692Z"
}